Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2017 Jan 27;7:41399. doi: 10.1038/srep41399

Evaluation of 10 SLE susceptibility loci in Asian populations, which were initially identified in European populations

Yue-miao Zhang 1, Xu-jie Zhou 1, Swapan K Nath 2, Celi Sun 2, Ming-hui Zhao 1, Hong Zhang 1,a
PMCID: PMC5269754  PMID: 28128292

Abstract

Ten novel loci have been found to be associated with systemic lupus erythematosus (SLE) susceptibility by a recent genome-wide association study conducted in Europeans. To test their disease associations and genetic similarities/differences in Asians and Europeans, we genotyped the 10 novel single nucleotide polymorphisms (SNPs) and performed an association study. A Chinese cohort from Northern China was recruited as the discovery population, and three East Asian cohorts were included for independent replication. The 10 SNPs were genotyped using TaqMan allele discrimination assays. To prioritize the associated SNPs, different layers of the public functional data were integrated. Among the 10 SNPs, rs564799 in IL12A was shared in both ethnicities (Padjust = 5.91 × 10−4; odds ratio = 1.22, 1.10–1.35). We also confirmed the reported polymorphism rs7726414 in TCF7 in the current study (Padjust = 4.12 × 10−8; odds ratio = 1.46, 1.28–1.66). The directions and magnitudes of the allelic effects for most of the 10 SNPs were comparable between Europeans and Asians. However, higher risk allele frequencies and population-attributable risk percentages were observed in Asians than in Europeans. We also identified the most likely functional SNPs at each locus. In conclusion, both genetic similarities and differences across ethnicities have been observed, providing further evidence for a genetic basis of the high incidence of SLE in Asian ancestry.


Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with complex genetic etiology that can affect the majority of organs and tissues. The strong familial aggregation and high disease concordance in monozygotic twins (24–56%) have suggested a genetic component to SLE predisposition1. To date, based on hypothesis-free genome-wide association studies (GWAS), 62 SLE susceptibility loci have been identified in single ancestries2, providing important clues for understanding the genetic architecture of SLE patients.

However, the incidence of SLE varies across different populations, with a markedly higher prevalence in Asians than in Europeans3,4, suggesting genetic heterogeneity across populations. Although it was suggested that most of the novel SLE risk loci identified by GWAS was shared between Asians and Europeans2,5, a trans-ancestral comparison study would be helpful for uncovering genetic heterogeneity and detecting novel susceptibility loci in different populations6. Recently, 10 novel SNPs have been identified by a GWAS of SLE in European populations7. Among them, rs7726414 in TCF7 has also been reported to be associated with Asian SLE patients8. Thus, in this study, by genotyping the 10 novel SNPs without selection, we initially tended to explore the genetic similarities/differences in Asians and Europeans by comparing the allelic associations, odds ratios (ORs), risk allele frequencies (RAFs), and population-attributable risk percentages (PARPs) of these novel risk alleles.

In addition to, considering that most of the SLE-associated variants are located in non-coding regions of the genome, the public Encyclopedia of DNA Elements (ENCODE) databases and expression quantitative trait loci (eQTL) mapping could provide us a novel perspective on interpreting functional single nucleotide polymorphisms (SNPs) with regulatory effects9. Thus, to prioritize the plausible functional SNPs and genes of the associated SNPs in this study, we integrated different layers of functional data, including DNase I hypersensitivity (DHS) analysis results, DNase I footprints, chromatin immunoprecipitation followed by sequencing (ChIP-seq) data, and eQTL mapping results according to the previous report10.

Results

Allelic association analyses

After quality control, 493 cases and 628 controls were included in the analysis. All 10 SNPs were in Hardy-Weinberg equilibrium in patients and controls (P > 0.05). As shown in Tables 1, three SNPs, including rs6740462 in SPRED2, rs564799 in IL12A, and rs2286672 in PLD2 have been significantly detected (with P values ranging from 3.51 × 10−2 to 9.36 × 10−5). The variant rs7726414 in TCF7 showed marginal significance in the discovery population (P = 5.37 × 10−2), while no solid evidence of associations was observed for the others (with P values of 0.16–0.77). For replication, genotype data for the 4 associated SNPs were then extracted from our previous study on East Asians, including Korean, Han Chinese and Malaysian Chinese8. Consistent associations of rs564799 in IL12A and rs7726414 in TCF7 have been observed, and the significances were enhanced by meta-analysis. Interestingly, the association between these two SNPs and SLE remained significant after multiple corrections (P values were 5.91 × 10−4 and 4.12 × 10−8, respectively, using the Bonferroni method on 4 SNPs) (Table 2). The effects of the two associated alleles were in the same direction (either risk or protective factors for SLE) as reported in Europeans.

Table 1. Associations between the 10 newly mapped loci and susceptibility to systemic lupus erythematosus.

SNP Risk allele Chr. Position (Build 37) Gene Discovery population (493 cases vs. 628 controls)
RAF (%) OR Allele P
rs6740462 A 2 65,667,272 SPRED2 81.6/77.3 1.30 (1.051.61) 1.50 × 10−2
rs3768792 G 2 213,871,709 IKZF2 20.4/19.1 1.08 0.46
rs564799 C 3 159,728,987 IL12A 89.8/84.1 1.67 (1.292.16) 9.36 × 10−5
rs7726414 T 5 133,431,834 TCF7 8.6/6.5 1.37 (1.001.88) 5.37 × 10−2
rs3794060 C 11 71,187,679 DHCR7, NADSYN1 49.0/48.3 1.03 0.77
rs10774625 A 12 111,910,219 SH2B3 99.6/99.3 0.62 0.43
rs4902562 A 14 68,731,458 RAD51B 59.9/56.8 1.13 0.16
rs9652601 G 16 11,174,365 CIITA, SOCS1 76.4/77.2 0.95 0.65
rs2286672 T 17 4,712,617 PLD2 41.9/37.3 1.21 (1.011.44) 3.51 × 10−2
rs887369 C X 30,577,846 CXorf21 97.2/96.7 1.20 0.48

(A) Chr: chromosome; RAF: risk allele frequency; OR: odds ratio; SNP: single nucleotide polymorphism.

(B) 95% confidence interval for OR values are presented only for significant associations in the square brackets.

Table 2. Independent replications of associated single nucleotide polymorphisms and meta-analysis.

SNP (risk allele) Discovery
Independent replication
 
Han Chinese in Beijing (493 cases vs. 628 controls)
Korean (1710 cases vs. 3167 controls)
Han Chinese (490 cases vs. 493 controls)
Malaysian Chinese (285 cases vs. 287 controls)
Meta-analysis
RAF% (case/control) Allele P RAF% (case/control) Allele P RAF% (case/control) Allele P RAF% (case/control) Allele P Adjusted Allele P* OR
rs6740462 (A) 81.6/77.3 1.50 × 10−2 84.0/83.4 0.44 79.3/76.5 0.13 84.9/81.6 0.13 0.12 1.09
rs564799 (C) 89.8/84.1 9.36 × 10−5 90.9/89.3 1.49 × 10−2 87.2/85.5 0.27 87.2/82.6 2.94 × 10−2 5.91 × 10−4 1.22 (1.101.35)
rs7726414 (T) 8.6/6.5 5.37 × 10−2 6.8/5.2 1.25 × 10−3 8.4/4.8 1.49 × 10−3 13.0/9.6 6.58 × 10−2 4.12 × 10−8 1.46 (1.281.66)
rs2286672* (T) 45.3/46.6 0.24 49.1/47.8 0.56 49.5/51.6 0.48 0.32 0.98

(A) RAF: risk allele frequency; OR: odds ratio; PARP: population-attributable risk percentage; SNP: single nucleotide polymorphism.

(B) *The genotype data of SNP rs2302327 in high linkage disequilibrium with rs2286672 (r2 = 0.98 in Asian population) was used for association analysis in Korean, Han Chinese and Malaysian Chinese populations and for the meta-analysis.

(C) 95% confidence interval for OR values are presented only for significant associations in the square brackets.

(D) *The allele P was adjusted using the Bonferroni method on 4 SNPs.

Detection powers for 10 SNPs in the Chinese Han population, assuming the odds ratios (ORs) in the published GWAS, are 55.1%, 61.6%, 71.7%, 75.8%, 80.9%, 92.6%, 95.1%, 95.7%, 96.8%, and 98.3% for rs9652601, rs887369, rs4902562, rs10774625, rs3768792, rs2286672, rs6740462, rs7726414, rs564799, and rs3794060, respectively. For the replicated 4 SNPs, rs7726414, rs564799, rs2286672, and rs6740462, genetic powers of the combined set of 2978 SLE cases and 4575 controls were 95.7%, 96.8%, 97.7%, and 99.5%. Thus, the un-replicated SNPs may be due to sample heterogeneity or limited detecting power (lower MAFs compared to Europeans).

Comparisons of risk allele frequencies, effect sizes and risk across cohorts

As shown in Table 3, the risk allele frequencies (RAFs) of all 10 SNPs in the controls were significantly higher in Asians than in Europeans, with P values ranging from 1.93 × 10−266 to 4.54 × 10−2. Especially for rs4902562 in RAD51B and rs2286672 in PLD2, the minor alleles in Europeans were the major alleles in Asians. Consistently with the clear differences in RAFs between Asians and Europeans, the PARPs were higher for most of the 10 SNPs in Asians than in Europeans, highlighting likely more pivotal roles in Asian patients2,5. Notably, the PARP value of the significant SNP rs564799 in IL12A was almost three times as high in Asians as in Europeans. In contrast, as mentioned in the former part, the effect size of all 10 SNPs, regarding the OR value and direction, were comparable in both Asians and Europeans.

Table 3. Comparison of risk allele frequencies, odds ratios and population-attributable risk percentages between Chinese and Europeans.

SNP Risk allele Gene Chinese/European controls (1121 vs. 15991)
OR (Chinese/European) PARP (Chinese/European)
RAF% Allele P
rs6740462 A SPRED2 77.0/73.5 9.44 × 10−3 1.23/1.20 15.05%/12.82%
rs3768792 G IKZF2 19.2/12.9 2.18 × 10−9 1.09/1.26 1.70%/3.25%
rs564799 C IL12A 84.7/59.3 3.27 × 10−64 1.37/1.15 23.86%/8.17%
rs7726414 T TCF7 5.7/4.4 4.54 × 10−2 1.53/1.46 2.93%/1.98%
rs3794060 C DHCR7, NADSYN1 49.5/25.6 4.20 × 10−68 1.19/1.13 8.60%/3.22%
rs10774625 A SH2B3 99.4/50.1 2.08 × 10−225 1.56/1.17 35.76%/7.85%
rs4902562 A RAD51B 58.8/41.7 2.83 × 10−29 1.09/1.13 5.03%/5.14%
rs9652601 G CIITA, SOCS1 76.2/66.8 6.96 × 10−11 1.04/1.17 2.96%/10.20%
rs2286672 T PLD2 38.1/7.1 1.93 × 10−266 1.18/1.24 6.42%/1.68%
rs887369 C CXorf21 97.0/74.7 1.36 × 10−64 1.16/1.16 13.43%/10.68%

(A) RAF: risk allele frequency; OR: odds ratio; PARP: population-attributable risk percentage; SNP: single nucleotide polymorphism.

(B) The significant associations were noted in bold.

Systematic annotation and prioritization of the functional SNPs

For the two replicated SNPs, 11 proxy SNPs (r2 > 0.8) were extracted, resulting in 13 candidate SNPs for functional annotation. Overall, we found that all of the variants located in non-coding regions of the genome and overlapped with at least one layer of ENCODE data, indicating that these SNPs are likely to influence SLE through mechanisms regulating gene expression. As shown in Table 4, in one context, for the lead SNP rs564799 and its proxies, rs485789 showed the most layers of functional information (i.e., the highest RegulomeDB score + Promoter/Enhancer histone marks and DNAse sites + protein-binding site + matched motifs). This concordance of peaks in rs485789 that correlated disease susceptibility with IL12A expression made this SNP a strong candidate as a functional SNP, with IL12A as the potentially causal genes. In another context, for the lead SNP rs7726414 and its proxies, rs7726414 intersected with the most layers of functional data (i.e., the highest RegulomeDB score + Promoter/Enhancer histone marks and DNAse sites + protein-binding site + matched motifs) and thus was prioritized as the most likely functional SNP. However, no cis-eQTL effects of rs7726414 and its proxies were identified in the databases applied in the current study.

Table 4. Detailed annotation information on the SLE-associated single nucleotide polymorphisms and their proxies.

Lead SNP Annotated gene Proxies (r2 in ASN) RegulomeDB score HaploReg v4.11
rSNPBase
cis-eQTL
Promoter/Enhancer histone marks and DNAse Proteins bound Regulatory motifs rSNP Proxy/Distal regulation seeQTL2 (q value) Selected eQTL hit3 (P value)
rs564799 IL12A rs485789 (1) 2b 9 9 4 yes yes 4.16 × 10−2 2.93 × 10−12
rs564799 IL12A rs4680536 (0.96) 4 6 0 2 no no 4.59 × 10−2 7.66 × 10−13
rs564799 IL12A rs485499 (0.97) 4 24 4 0 no no 4.57 × 10−12
rs564799 IL12A rs4679867 (1) 5 3 0 0 yes yes 4.57 × 10−12
rs564799 IL12A rs564799 (1) 5 2 0 0 yes yes 0.18 2.93 × 10−12
rs564799 IL12A rs564976 (1) 5 3 0 1 yes yes 2.69 × 10−12
rs564799 IL12A rs589446 (1) 6 0 0 4 yes yes 3.09 × 10−12
rs564799 IL12A rs55740284 (0.93) no evidence 0 0 1 yes yes
rs7726414 TCF7 rs4388254 (1) 4 17 0 0 no no
rs7726414 TCF7 rs7726414 (1) 4 12 1 4 no no
rs7726414 TCF7 rs6874758 (0.98) 5 9 0 5 no no
rs7726414 TCF7 rs10077437 (0.98) 6 1 0 2 no no
rs7726414 TCF7 rs10463912 (0.89) no evidence 0 0 5 no no

(A) ASN: Asian; eQTL: expression quantitative locus; rSNP: regulatory single nucleotide polymorphism; SLE: systemic lupus erythematosus; SNP: single nucleotide polymorphism.

(B) 1The numbers indicate cell types with experimentally validated regulatory elements. 2SeeQTL is a comprehensive and versatile eQTL database, including various eQTL studies and a meta-analysis of HapMap eQTL information (http://www.bios.unc.edu/research/genomic_software/seeQTL/). 3The selected eQTL hit in this study was driven by the analysis results of mRNA from lymphoblastoid cell lines of 462 individuals from the 1000 Genomes Project (PMID: 24037378).

Discussion

By investigating the 10 SLE related SNPs in 3 independent East Asian SLE populations, we detected one significant novel loci (IL12A) and confirmed one previously reported one (TCF7)8. With the current replication population, the statistical power for the two significant association signals were 96.8% and 95.7%, respectively. Notably, the locus IL12B was identified as novel related genes for SLE in East Asian populations by high-density genotyping8, emphasizing the validity and immune relevance of these regions. Moreover, markedly higher RAFs and PARPs for these SNPs were observed in Asian populations compared with Europeans, providing further evidence for a genetic background for the difference in prevalence. The risk alleles and their effects (both effect size and direction) were shared by Asians and Europeans. Consistently with previous studies2,5, both similarities and differences with respect to RAFs, PARPs and ORs were observed across ethnicities.

Although, the genetic heterogeneity across ancestries would cause different association results. For the 8/10 SNPs for which we did not detect consistent association signals in the current study, different distributions of RAFs and PARPs were also observed. Even using a similar number of cases and controls for both ethnicities, differences in the power to detect significant associations for individuals SNPs across ethnicities appear to depend largely on their allele frequencies. As mentioned above, the detection powers for the 8/10 un-replicated SNPs were about 50–80%. In future work, independent replication in larger populations, especially for the SNPs with lower allele frequencies, will be needed.

More importantly, using the public available databases, we have been able to zoom in on the functional SNPs of the significant SNPs rs564799 and rs7726414, which were proposed to affect the SLE pathology. We found that most of the SLE-related SNPs were located in non-coding regions of the genome and played a role in disease pathogenesis through altering the target gene expression. On one hand, rs485789 in high LD with rs564799 (r2 = 1) showed the strongest regulatory evidence among the lead SNP rs564799 and its proxies. It also had a cis-eQTL effect on IL12A, indicating rs485789 as the functional SNP and IL12A as the potential causal gene. IL12A encodes IL-12α, which is a component of IL-12 (made in B cells, macrophages, dendritic cells and neutrophils). IL-12 is a critical secreted signal in T cell activation. On the other hand, the lead SNP rs7726414 itself was annotated as the strongest regulatory variant. Although no cis-eQTL effects of rs7726414 have been detected in the current study, the annotated gene TCF7 seemed more likely to be the causal gene. TCF7 is a T cell–specific transcription factor that regulates the expression of CD3. A mouse Tcf7 knockout showed reduced immune-competence of T cells in the periphery. Thus, further fine-mapping analysis and functional studies are still needed to clarify the role of TCF7 in the pathogenesis of SLE.

In summary, two novel loci reported by SLE GWAS in Europeans have been significantly replicated in three independent East Asian populations. The comparison of RAFs and PARPs in Europeans and Asians provides further evidence for a genetic basis of the high incidence of SLE in Asia compared to Europe. By integrating multiple layers of regulatory information and eQTL mapping, the functional SNPs and genes have been detected.

Materials and Methods

Subjects

The current association analysis was conducted in two stages. In the discovery stage, a discovery cohort of Chinese Han ancestry from Northern China was recruited, including 493 SLE cases (age 32.52 ± 12.31 years, female 86.07%) and 628 unrelated healthy controls (age 41.40 ± 11.01 years). In the replication stage, three independent East Asian cohorts, including Koreans, Han Chinese and Malaysian Chinese8, were included to validate the associated SNPs (P < 0.1). A flowchart of the current study is presented in Fig. 1.

Figure 1. Workflow of our study design.

Figure 1

The study was designed in three stages. First, we genotyped the 10 novel genome wide associated loci with European SLE patients in a Han Chinese cohort in Beijing and compared the genetic similarities and differences between the two ancestries. Four out of 10 loci were identified as significant (P < 0.1). Second, we performed independent replications of these 4 loci in three cohorts from Korean, Han Chinese and Malaysian Chinese. Consistent associations have been identified in our discovery and replication cohorts for two loci (i.e., IL12A and TCF7). Third, by integrating different layers of functional data, we identified the most likely functional SNPs for these two loci. Abbreviations: GWAS: genome-wide association study; SLE: systemic lupus erythematosus; SNP: single nucleotide polymorphism.

All the patients met the revised SLE criteria of American College of Rheumatology11. This investigation was conducted according to the Declaration of Helsinki. The medical ethics committee of Peking University approved the study. All participants gave informed consent.

SNP selection and genotyping

Although the variant rs7726414 in TCF7 was also discovered and replicated in our previous study8, for consistency and to assess the replication, we evaluated the 10 novel SNPs reported in a recent SLE GWAS conducted in Europeans7 without selection. Genotyping was conducted using TaqMan allele discrimination assays as previously reported12,13,14.

To comprehensively evaluate the genetic heterogeneity between Asians and Europeans, we retrieved the summary data of the 10 SNPs from the published SLE GWAS in Europeans7. The Han Chinese replication population8 were also included for the analysis because both this population and the discovery population were recruited from Northern China. Genotype data for 5 SNPs, including rs6740462, rs564799, rs7726414, rs10774625, and rs9652601, were extracted from the Immunochip, while the remaining 5 SNPs for this cohort were genotyped using TaqMan allele discrimination assays.

Systematic annotation

To prioritize potential functional SNPs and causal genes at the replicated susceptibility loci, we integrated multiple functional data. The detailed procedures of the prioritization process were presented in Fig. 2. Considering that there are often SNPs showing high linkage disequilibrium (LD) with the associated SNPs, we first extracted the proxies (r2 > 0.8, 1000 Genomes Project, Asian population as reference) for the significant replicated SNPs using the HaploReg v4.1 database (http://www.broadinstitute.org/mammals/haploreg/haploreg.php), forming the candidate SNPs. The potential functional consequences of the candidate SNPs were predicted using rSNPBase (http://rsnp.psych.ac.cn/) and RegulomeDB databases (http://www.regulomedb.org/). The rSNPBase database provides the regulatory information on SNPs with experimentally validated regulatory elements controlling transcriptional and post-transcriptional events. RegulomeDB ranks SNPs based on the amount of regulatory information with which an SNP intersects. Then, the eQTL mapping data were used to prioritize the replicated SNPs. As a discovery set, the comprehensive and versatile eQTL database seeQTL (http://www.bios.unc.edu/research/genomicsoftware/seeQTL/), which includes various eQTL studies and a meta-analysis of HapMap eQTL information, was investigated, and the results were replicated in lymphoblastoid cell lines of 462 individuals from the 1000 Genomes Project15.

Figure 2. Annotation strategy for the significant variants and their proxies.

Figure 2

The figure shows the detailed strategy of our annotation approach used to prioritize functional SNPs. HaploReg v4.1 (http://www.broadinstitute.org/mammals/haploreg/haploreg.php) was used to search proxies (r2 ≥ 0.8 in Asian) of the associated SNPs and their binding motifs and epigenetic marks. The rSNPBase (http://rsnp.psych.ac.cn/) database was used to search for regulatory SNPs with experimentally validated regulatory elements controlling transcriptional and post-transcriptional events. RegulomeDB (http://www.regulomedb.org/) was used to search for the regulatory scores of SNPs according to their amount of regulatory information. Abbreviations: eQTL: expression quantitative trait locus; GWAS: genome-wide association study; rSNP: regulatory single nucleotide polymorphism; SLE: systemic lupus erythematosus; SNP: single nucleotide polymorphism.

Statistical analysis

Quality control of genotyping, Hardy-Weinberg equilibrium tests, allelic association analyses were performed using PLINK16. As a replication, no multiple testing was applied, and P < 0.05 was considered significant. ORs and allele frequencies were presented according to the risk alleles identified in Europeans. The contributions of SNPs to the risk of SLE were estimated with PARP, which considers both OR and RAF in the general population, using the formula RAF(OR-1)/[RAF(OR-1) + 1] × 100%17. Statistical power was estimated using Power and Sample Size Calculations Version 3.0 (http://biostat.mc.vanderbilt.edu/PowerSampleSize) with a two-sided type I error rate of 0.05.

Additional Information

How to cite this article: Zhang, Y.-m. et al. Evaluation of 10 SLE susceptibility loci in Asian populations, which were initially identified in European populations. Sci. Rep. 7, 41399; doi: 10.1038/srep41399 (2017).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Acknowledgments

This work was supported by grants from the Beijing Natural Science Foundation (7152148), the National Natural Science Foundation of China (81570629), the Chinese Society of Nephrology (15020030591), the Beijing Municipal Science and Technology for the Outstanding PhD Program (20121000110), the Natural Science Fund of China to the Innovation Research Group (81021004), and the National Key Technology R&D Program (2013BAI09B14).

Footnotes

The authors declare no competing financial interests.

Author Contributions Yue-miao Zhang, Xu-jie Zhou, Swapan K. Nath, Celi Sun, Ming-hui Zhao, and Hong Zhang are co-authors on this manuscript. Hong Zhang is the senior author on this manuscript. Yue-miao Zhang, Xu-jie Zhou, and Hong Zhang conceived and designed the experiments. Yue-miao Zhang performed the experiments. Yue-miao Zhang, Xu-jie Zhou, Swapan K. Nath, and Celi Sun analyzed the data. Yue-miao Zhang wrote the manuscript. All authors reviewed the manuscript.

References

  1. Deng Y. & Tsao B. P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 6, 683–92 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Morris D. L. et al. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nat Genet 48, 940–6 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borchers A. T., Naguwa S. M., Shoenfeld Y. & Gershwin M. E. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9, A277–87 (2010). [DOI] [PubMed] [Google Scholar]
  4. Danchenko N., Satia J. & Anthony M. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15, 308–18 (2006). [DOI] [PubMed] [Google Scholar]
  5. Wang C. et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur J Hum Genet 21, 994–9 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fu J., Festen E. A. & Wijmenga C. Multi-ethnic studies in complex traits. Hum Mol Genet 20, R206–13 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bentham J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 47, 1457–64 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sun C. et al. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat Genet 48, 323–30 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dunham I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kumar V. et al. Systematic annotation of celiac disease loci refines pathological pathways and suggests a genetic explanation for increased interferon-gamma levels. Hum Mol Genet 1524, 397–409 (2015). [DOI] [PubMed] [Google Scholar]
  11. Hochberg M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40, 1725 (1997). [DOI] [PubMed] [Google Scholar]
  12. Zhou X. J. et al. Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann Rheum Dis 70, 1330–7 (2011). [DOI] [PubMed] [Google Scholar]
  13. Zhou X. J. et al. Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus. Arthritis Rheum 64, 222–31 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Zhou X. J. et al. Brief Report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern Han Chinese by shared-gene analysis with IgA nephropathy. Arthritis Rheumatol 66, 2842–8 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lappalainen T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 26501, 506–11 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Purcell S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559–75 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cole P. & MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med 25, 242–4 (1971). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES